4. Botulinum toxin type‐A on radiographic alignment, Foot Posture Index, ankle dorsiflexion range of motion, foot strength.

Outcome Measure	No. of participants	Control Leg	BoNT‐A Leg	Statistical Method	Effect Size
Change of calcaneal‐first metatarsal angle	10	‐3.2 (4.2)	‐2.2 (3.3)	WMD (fixed), 95% CI	1.00 (‐2.31 to 4.31)
Change of tibia‐calcaneal angle	10	‐2.1 (3.7)	‐1.0 (2.9)	WMD (fixed), 95% CI	1.10 (‐1.81 to 4.01)
Change of Foot Posture Index	10	1.3 (2.5)	‐0.2 (2.4)	WMD (fixed), 95% CI	‐1.50 ‐3.65 to 0.65)
Change of ankle dorsiflexion range of motion	10	5.3 (7.4)	3.1 (6.3)	WMD (fixed), 95% CI	‐2.20 ‐8.22 to 3.82)
Change of dorsiflexion foot strength	10	19.5 (22.7)	19.9 (24.8)	WMD (fixed), 95% CI	0.40 (‐20.44 to 21.24)
Change of plantarflexion foot strength	10	50.6 (58.1)	61.5 (59.9)	WMD (fixed), 95% CI	10.90 (‐40.82 to 62.62)
Change of inversion foot strength	10	28.8 (40.4)	35.8 (35.2)	WMD (fixed), 95% CI	7.00 (‐26.21 to 40.21)
Change of eversion foot strength	10	31.0 (34.5)	24.8 (26.0)	WMD (fixed), 95% CI	‐6.20 (‐32.98 to 20.58)